By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Genocea Biosciences 

161 1st Street
Suite 2C
Cambridge  Massachusetts    U.S.A.
Phone: 617-876-8191 Fax: 617-500-0969



Start Up

Company News
Genocea Biosciences Announces Positive Top-Line Phase 2 Data For Genital Herpes Immunotherapy GEN-003 5/20/2015 12:02:33 PM
Genocea Biosciences To Present At The UBS Global Healthcare Conference 5/13/2015 11:24:55 AM
Genocea Biosciences Reports First Quarter 2015 Financial Results 5/7/2015 12:58:22 PM
Genocea Biosciences To Host First Quarter 2015 Financial Results Conference Call & Webcast On May 7, 2015 5/1/2015 9:44:31 AM
Genocea Biosciences Completes Enrollment In Phase IIa Human Challenge Study Of GEN-004 For The Prevention Of Infection By Pneumococcus 4/22/2015 8:34:07 AM
Genocea Biosciences To Present At The 14th Annual Needham & Co. Healthcare Conference 4/8/2015 10:00:56 AM
Genocea Biosciences Announces Closing Of $51.7 Million Public Offering Of Common Stock And Exercise In Full Of Underwriters’ Option To Purchase Additional Shares 3/17/2015 9:32:19 AM
Genocea Biosciences Announces Pricing Of $45 Million Public Offering 3/12/2015 8:05:04 AM
Genocea Biosciences Appoints Michael Higgins To Its Board Of Directors 2/27/2015 11:09:10 AM
Genocea Biosciences To Present At The Cowen and Company 35th Annual Health Care Conference 2/25/2015 10:52:09 AM